Université de Paris, Faculté de Médecine, F-75006, Paris, France; Department of Paediatric Otolaryngology, AP-HP, Hôpital Necker-Enfants Malades, F-75015, Paris, France.
Université de Paris, Faculté de Médecine, F-75006, Paris, France; Department of Paediatric Otolaryngology, AP-HP, Hôpital Necker-Enfants Malades, F-75015, Paris, France.
Int J Pediatr Otorhinolaryngol. 2021 Jun;145:110706. doi: 10.1016/j.ijporl.2021.110706. Epub 2021 Apr 6.
Chronic rhinosinusitis (CRS) is a frequent, quality-of-life (QOL) impairing disease in pediatrics. The SN-5 is a reliable, sensitive and reproductible QOL questionnaire, validated in English for evaluation of CRS disease-specific QOL in children. This study aims to adapt and validate the French version of this test.
The SN-5 score was adapted into French language through a forward-backwards translation process, and validated through a monocentric prospective controlled study. Inclusion criteria were 2-12 years of age, CRS symptoms for at least 12 weeks, or absence of sino-nasal symptom for controls. Reproducibility was assessed through Spearman's correlation between initial answers and a re-test conducted 15 days later. Internal consistency was measured through Cronbach's alpha, construct validity through Spearman's correlation between items, discriminative ability through Mann-Whitney tests.
40 patients and 37 controls filled the score between November 2019 and March 2020. Retest was returned by 35 patients and 35 controls. Mean cases age was 8.5 ± 2.6 years old. 26 patients had primary CRS, 10 had cystic fibrosis, 4 had ciliary dyskinesia. All had diffuse disease. Mean SN-5 overall score was 3.63/7 ± 6.4 for CRS patients and 1.89/7 ± 0.9 for controls (p < 0.001). Test-retest coefficient was 0.84 (0.70-0.92; p < 0.001), Cronbach's alpha was 0.83 for CRS patient. Item per item construct validity was good to excellent.
The French version of the SN-5 showed good statistical properties, with good test-retest reliability, internal consistency, structural validity and discriminative ability between CRS and control patients.
慢性鼻-鼻窦炎(CRS)是儿科常见的、影响生活质量(QOL)的疾病。SN-5 是一种可靠、敏感和可重复的 QOL 问卷,已在英语中验证用于评估儿童 CRS 疾病特异性 QOL。本研究旨在改编和验证该测试的法语版本。
通过正向-反向翻译过程将 SN-5 评分改编为法语,并通过单中心前瞻性对照研究进行验证。纳入标准为 2-12 岁,CRS 症状至少 12 周,或对照者无鼻窦症状。通过初始回答与 15 天后进行的重新测试之间的 Spearman 相关系数评估可重复性。内部一致性通过 Cronbach's alpha 进行测量,结构有效性通过项目之间的 Spearman 相关系数进行测量,区分能力通过 Mann-Whitney 检验进行测量。
2019 年 11 月至 2020 年 3 月期间,40 名患者和 37 名对照者填写了评分。35 名患者和 35 名对照者返回了复测。平均病例年龄为 8.5±2.6 岁。26 名患者患有原发性 CRS,10 名患者患有囊性纤维化,4 名患者患有纤毛运动障碍。所有患者均患有弥漫性疾病。CRS 患者的 SN-5 总体评分为 3.63/7±6.4,对照组为 1.89/7±0.9(p<0.001)。测试-重测系数为 0.84(0.70-0.92;p<0.001),CRS 患者的 Cronbach's alpha 为 0.83。项目间结构有效性良好至优秀。
SN-5 的法语版本具有良好的统计学特性,具有良好的测试-重测可靠性、内部一致性、结构有效性和 CRS 与对照组患者之间的区分能力。